Category Archives: News

SOM BIOTECH AT BIO-EUROPE 2014 IN FRANKFURT

SOM Biotech will attend next BIO-Europe, Europe’s largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. It is regarded as a “must attend” event for the biotech industry. This event will take place in Frankfurt from 3-5 November …

SOM BIOTECH OBTAINS THE APPROVAL FROM REGULATORY AUTHORITIES TO CARRY OUT THE PHASE IIA CLINICAL TRIAL FOR TTR AMYLOIDOSIS

SOM Biotech has just obtained the approval from the Ethics Committee of Hopital Vall d’Hebron and the Spanish Medicines Agency (AEMPS) to start the Phase IIa clinical trial of its compound SOM0226 indicated for transthyretin Amyloidosis. This trial will be jointly coordinated by SOM Biotech and Vall d’Hebron Research Institute (VHIR). The principal investigator of …

SOM BIOTECH AT BIO INTERNATIONAL CONVENTION 2014

SOM Biotech will attend next BIO International Convention through its Canadian partner Willow Tree Capital Group (WTCG). If you are interested in knowing more about SOM’s current programs, you can reach WTCG or also visit the Spain Pavilion Booth 4117 and ask for the BioRegion of Catalonia Private Foundation (BIOCAT). This event will take place …

4TH INTERNATIONAL MEETING OF PEOPLE AFFECTED BY ALS

SOM Biotech will attend the 4th International Meeting of People affected by ALS (Amyotrophic Lateral Sclerosis). Burgos (Spain), 6th-11th April 2014. SOM Biotech will take part in the 4th International Meeting of People with ALS and Researchers organized jointly by the Spanish Ministry of Health and the Association of People Affected by ELA. The sessions …

SOM BIOTECH AT BIO-EUROPE SPRING 2014

SOM Biotech attended Bio-Europe Spring 2014 in Turin. 2,000 high-level executives from pharma, biotech, venture capital firms, and service companies were present at this event and over 11,000 partnering meetings took place in just three days. SOM Biotech was able to meet several delegates from medium-big pharma companies. ( http://www.ebdgroup.com/bes/index.php)